Research | OneLook Acronym Finder |
Serial Number | 79257674 |
Registration Number | 6026139 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Julie A. Greenberg |
Attorney Docket Number | 67718- |
Law Office Assigned | M20 |
Employee Name | FALK, JONATHAN ROBERT |
2018-12-06 | Application Filed |
2019-12-17 | Location: PUBLICATION AND ISSUE SECTION |
2019-12-17 | Status: Live/Pending |
2020-01-01 | Transaction Date |
2020-01-21 | Published for Opposition |
2020-04-07 | Trademark Registered |
Owner: | Immudex ApS |
Address | Fruebjergvej 3 DK-2100 Copenhagen à DK |
Legal Entity Type | Private Limited Company |
Legal Entity State | DK |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0011 | Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes |
GS0011 | Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-05-02 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-05-06 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2019-05-06 | 3 DOCK D:Assigned to Examiner |
APPLICATION FILING RECEIPT MAILED | 2019-05-10 | 4 MAFR O:Outgoing Correspondence |
NON-FINAL ACTION WRITTEN | 2019-05-10 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-05-11 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2019-06-05 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-06-05 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2019-06-22 | 9 RFNP P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-11-29 | 10 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2019-12-11 | 11 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-17 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-17 | 13 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-12-17 | 14 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-01-01 | 15 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-01-01 | 16 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-01-01 | 17 OPNS P: |
NOTIFICATION PROCESSED BY IB | 2020-01-17 | 18 GPNX P: |
PUBLISHED FOR OPPOSITION | 2020-01-21 | 19 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-01-21 | 20 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2020-04-07 | 21 R.PR A:Allowance for Publication |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-07-07 | 22 FICR P: |
FINAL DISPOSITION PROCESSED | 2020-08-14 | 23 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2020-08-14 | 24 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-09-05 | 25 FINO P: |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-07-12 | 26 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-12 | 27 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-12 | 28 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-12 | 29 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-07-12 | 30 CHAN I:Incoming Correspondence |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2022-01-21 | 31 ADCH M: |
NEW REPRESENTATIVE AT IB RECEIVED | 2023-04-02 | 32 NREP P: |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-04-14 | 33 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-04-14 | 34 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-04-14 | 35 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-04-14 | 36 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-04-14 | 37 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-04-14 | 38 CHAN I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.